Compugen Ltd. , a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe.
Compugen stock last closed at $1.38, up 2.99% from the previous day, and has decreased 28.13% in one year. It has overperformed other stocks in the Biotechnology industry by 0.22 percentage points. Compugen stock is currently +22.12% from its 52-week low of $1.13, and -48.12% from its 52-week high of $2.66.
At the moment, there are 93.54M CGEN shares outstanding. The market capitalization of CGEN is $129.08M. In the last 24 hours, 465,000 CGEN shares were traded.
You will need an online brokerage account in order to access the NASDAQ market and buy CGEN shares.
Based on our experience, eToro is the best place to buy stocks. Here's why:
Get $10 towards your purchase of shares by opening an account with eToro today. This offer is only for US users.
Open eToro AccountNow that you've selected the best brokerage, you need to fill out some personal info so you can buy CGEN today.
Now that you've opened your account on stock market app, your next step is to transfer the money for your investment:
Watch this video walkthrough to see the process of depositing funds into your brokerage account.
Once you have decided on the best place to buy Compugen stock, it's critical to research their stock prior to buying, so you can wrap your head around the risk as well as the opportunity.
WallStreetZen was designed to help part-time investors do better fundamental analysis in less time.
You can view all of the due diligence checks on CGEN's stock page.
Investors use many financial metrics, analyses, models, and charts to gauge CGEN's fair value.
Using relative valuations metrics:
You can access more valuation analysis on CGEN's stock here.
You can dive deeper into what analysts are saying on the Compugen stock forecast page.
Last year, CGEN revenue was $22.14M. During the past four year, CGEN's revenue has gone up by 82.41% per year. This was faster than the Biotechnology industry average of 67.8%.
You can research CGEN's earnings and revenue performance here.
In the past year, insiders at CGEN have not bought or sold any shares.
Get more info about who owns CGEN stock here.
No, Compugen doesn't provide an income stream by paying out dividends.
One of the biggest reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other community members have to say.
You have two primary order types:
Press the Open button and your broker will execute your order.
If you require additional help investing in stocks on eToro, click the how to video below:
Now that you own some shares in CGEN, you'll want to keep up with your new investment.
Make a watchlist to track the latest developments regarding your CGEN stock.
To reiterate, here are the 6 steps to buy Compugen stock:
If you are looking for a brokerage account, eToro is our favorite option.
Get Started with eToro TodayIf you want to get the latest news on your investment in Compugen, click below.